Related Experiment Video
Updated: May 17, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
[Hyperglycaemia and Acute Coronary Syndrome]
A Grembiale1, C Cloro, F Iorio
1Dipartimento di Scienze Mediche e Chirurgiche, Università degli Studi Magna Graecia di Catanzaro, Unità Operativa Complessa di Cardiologia, Ospedale SS Annunziata di Cosenza, Catanzaro, Italia.
La Clinica Terapeutica
|October 27, 2012
Summary
High blood sugar (hyperglycaemia) in Acute Coronary Syndrome (ACS) patients is common and linked to worse outcomes. Intensive glucose control shows promise but requires more research to balance benefits against risks like hypoglycemia.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Syndrome
Context:
- Hyperglycaemia is prevalent in Acute Coronary Syndrome (ACS) patients.
- It independently predicts mortality and morbidity, irrespective of diabetes status.
- Hyperglycaemia can stem from pre-existing diabetes, glucose intolerance, or a stress response.
Purpose:
- To evaluate the impact of intensive hyperglycaemia management in ACS patients.
- To explore the benefits of intensive metabolic treatment in counteracting adverse effects.
- To identify challenges, particularly hypoglycemia, associated with intensive glucose control.
Summary:
- Intensive hyperglycaemia control in ACS patients may improve short- and long-term outcomes.
- The primary challenge is hypoglycemia, which carries risks of mortality and myocardial re-infarction.
- Current data on intensive insulin treatment benefits are inconclusive.
Impact:
- Further randomized multicenter clinical trials are necessary.
- Definitive data are needed to establish the efficacy of intensive glucose control in reducing mortality and complications in hospitalized ACS patients with hyperglycaemia.
Related Concept Videos
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...